{
    "id": "dbpedia_4910_0",
    "rank": 28,
    "data": {
        "url": "https://pubmed.ncbi.nlm.nih.gov/29491067/",
        "read_more_link": "",
        "language": "en",
        "title": "Clinicopathological and Prognostic Significance of Epithelial Gremlin1 Expression in Gastric Cancer",
        "top_image": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image-v2.jpg",
        "meta_img": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image-v2.jpg",
        "images": [
            "https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png",
            "https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg",
            "https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg",
            "https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg",
            "https://cdn.ncbi.nlm.nih.gov/pubmed/a266f1b7-df1a-4da4-b828-cfe0d573f6ff/core/images/pubmed-logo-blue.svg",
            "https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--highwire.stanford.edu-icons-externalservices-pubmed-standard-anticanres_full.gif",
            "https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--highwire.stanford.edu-icons-externalservices-pubmed-standard-anticanres_full.gif"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "pmid:29491067",
            "doi:10.21873/anticanres.12366",
            "Ririno Honma",
            "Naoya Sakamoto",
            "Wataru Yasui",
            "Adult",
            "Aged",
            "Aged",
            "80 and over",
            "Biomarkers",
            "Tumor / biosynthesis*",
            "Disease Progression",
            "Female",
            "Gastric Mucosa / metabolism*",
            "Gastric Mucosa / pathology",
            "Humans",
            "Immunohistochemistry",
            "Intercellular Signaling Peptides and Proteins / biosynthesis*",
            "Kaplan-Meier Estimate",
            "Male",
            "Middle Aged",
            "Multivariate Analysis",
            "Prognosis",
            "Stomach Neoplasms / metabolism*",
            "Stomach Neoplasms / pathology",
            "PubMed Abstract",
            "NIH",
            "NLM",
            "NCBI",
            "National Institutes of Health",
            "National Center for Biotechnology Information",
            "National Library of Medicine",
            "MEDLINE"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "These results indicate that Gremlin1 could be involved in GC progression and may be a good marker of long-term survival in GC.",
        "meta_lang": "en",
        "meta_favicon": "https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico",
        "meta_site_name": "PubMed",
        "canonical_link": "https://pubmed.ncbi.nlm.nih.gov/29491067/",
        "text": "Background/aim: Gastric cancer (GC) is one of the most common malignancies worldwide. Gremlin1 is an antagonist of bone morphogenetic proteins that plays a critical role in several biological processes including cancer biology.\n\nMaterials and methods: We immunohistochemically examined the expression and distribution of Gremlin1 in non-neoplastic gastric mucosa in a series of 159 GC cases.\n\nResults: Among 159 GC primary tumors, 59 (37%) were positive for Gremlin1. Gremlin1-negative GC cases showed significantly more advanced clinicopathologic factors and a trend toward intestinal-type GC. Gremlin1 expression was also frequently observed in MUC5AC-positive and G-type GC cases. Gremlin1-negative GCs had a poorer survival rate than Gremlin1-positive GCs (p=0.002). Univariate and multivariate analyses revealed that Gremlin1 expression is an independent predictor of survival in GCs."
    }
}